|
🐢
|
Missing value estimation methods for DNA microarrays
8 auth.
O. Troyanskaya,
M. Cantor,
G. Sherlock,
P. Brown,
T. Hastie,
R. Tibshirani,
...
D. Botstein,
R. Altman
|
11 |
2001 |
11
🐢
|
|
🐜
|
Pharmacogenomics Knowledge for Personalized Medicine
8 auth.
Michelle Whirl‐Carrillo,
E. McDonagh,
J. Hebert,
L. Gong,
K. Sangkuhl,
C. Thorn,
...
R. Altman,
T. Klein
|
10 |
2012 |
10
🐜
|
|
🐜
|
Estimation of the warfarin dose with clinical and pharmacogenetic data.
12 auth.
T. Klein,
R. Altman,
N. Eriksson,
B. Gage,
S. Kimmel,
M-T M Lee,
...
N. Limdi,
D. Page,
D. Roden,
M. Wagner,
M. Caldwell,
J. A. Johnson
|
10 |
2009 |
10
🐜
|
|
🐜
|
Diversity of gene expression in adenocarcinoma of the lung
14 auth.
M. Garber,
O. Troyanskaya,
K. Schluens,
S. Petersen,
Zsuzsanna Thaesler,
M. Pacyna‐Gengelbach,
M. van de Rijn,
G. Rosen,
C. Perou,
R. Whyte,
...
R. Altman,
P. Brown,
D. Botstein,
I. Petersen
|
10 |
2001 |
10
🐜
|
|
🐢
|
Doxorubicin pathways: pharmacodynamics and adverse effects
7 auth.
C. Thorn,
C. Oshiro,
S. Marsh,
T. Hernandez-Boussard,
H. McLeod,
T. Klein,
...
R. Altman
|
10 |
2011 |
10
🐢
|
|
🐜
|
Guidelines for investigating causality of sequence variants in human disease
32 auth.
D. MacArthur,
D. MacArthur,
T. Manolio,
D. Dimmock,
H. Rehm,
J. Shendure,
G. Abecasis,
D. Adams,
R. Altman,
S. Antonarakis,
Euan A. Ashley,
J. Barrett,
L. Biesecker,
D. Conrad,
G. Cooper,
...
Nancy J. Cox,
M. J. Daly,
M. J. Daly,
M. Gerstein,
David B. Goldstein,
J. Hirschhorn,
J. Hirschhorn,
S. Leal,
L. Pennacchio,
L. Pennacchio,
J. Stamatoyannopoulos,
S. Sunyaev,
David Valle,
B. Voight,
W. Winckler,
W. Winckler,
C. Gunter
|
10 |
2014 |
10
🐜
|
|
🐜
|
Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
40 auth.
Rui Chen,
G. Mias,
J. Li-Pook-Than,
Lihua Jiang,
Hugo Y. K. Lam,
Rong Chen,
E. Miriami,
K. Karczewski,
M. Hariharan,
F. Dewey,
M. Clark,
Hogune Im,
L. Habegger,
S. Balasubramanian,
Maeve O’Huallachain,
...
J. Dudley,
Sara Hillenmeyer,
R. Haraksingh,
Donald Sharon,
G. Euskirchen,
P. Lacroute,
K. Bettinger,
A. Boyle,
Maya Kasowski,
Fabian Grubert,
Scott M. Seki,
Marco A Garcia,
Michelle Whirl‐Carrillo,
M. Gallardo,
M. Blasco,
P. Greenberg,
P. Snyder,
T. Klein,
R. Altman,
A. Butte,
E. Ashley,
M. Gerstein,
K. Nadeau,
Hua Tang,
Michael P. Snyder
|
10 |
2012 |
10
🐜
|
|
🐜
|
The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes
14 auth.
Maureen Hillenmeyer,
E. Fung,
Jan Wildenhain,
Sarah E. Pierce,
Shawn Hoon,
William Lee,
M. Proctor,
Robert P. St.Onge,
M. Tyers,
D. Koller,
...
R. Altman,
Ronald W. Davis,
C. Nislow,
G. Giaever
|
9 |
2008 |
9
🐜
|
|
🐢
|
MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES
S. Raychaudhuri,
Joshua M. Stuart,
R. Altman
|
9 |
1999 |
9
🐢
|
|
🐜
|
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features
7 auth.
Kun‐Hsing Yu,
Ce Zhang,
G. Berry,
R. Altman,
Christopher Ré,
D. Rubin,
...
M. Snyder
|
9 |
2016 |
9
🐜
|
|
🐢
|
Data-Driven Prediction of Drug Effects and Interactions
N. Tatonetti,
Patrick Ye,
Roxana Daneshjou,
R. Altman
|
9 |
2012 |
9
🐢
|
|
🐢
|
Clinical assessment incorporating a personal genome
31 auth.
E. Ashley,
A. Butte,
M. Wheeler,
Rong Chen,
T. Klein,
F. Dewey,
J. Dudley,
K. Ormond,
A. Pavlovic,
Alexander A. Morgan,
D. Pushkarev,
N. Neff,
L. Hudgins,
L. Gong,
L. Hodges,
...
D. Berlin,
C. Thorn,
K. Sangkuhl,
J. Hebert,
Mark Woon,
H. Sagreiya,
R. Whaley,
J. Knowles,
M. Chou,
J. Thakuria,
A. Rosenbaum,
A. Zaranek,
G. Church,
H. Greely,
S. Quake,
R. Altman
|
9 |
2010 |
9
🐢
|
|
🐢
|
Machine learning in chemoinformatics and drug discovery.
Yu-Chen Lo,
Stefano E. Rensi,
Wen Torng,
R. Altman
|
9 |
2018 |
9
🐢
|
|
🐜
|
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
17 auth.
P. Burridge,
Y. F. Li,
Elena Matsa,
Haodi Wu,
S. Ong,
Arun Sharma,
Alexandra Holmström,
Alex C. Y. Chang,
Michael Coronado,
Antje D. Ebert,
...
J. Knowles,
M. Telli,
R. Witteles,
H. Blau,
D. Bernstein,
R. Altman,
Joseph C. Wu
|
9 |
2016 |
9
🐜
|
